Data / Form D filings / Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc.: Form D filings
Mediar Therapeutics, Inc., a biotechnology company in Boston, MA, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on December 23, 2025, reports $37.8 million sold of a $75.7 million offering to 18 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 OVERLAND STREET, SUITE 520, Boston, MA, 02215
- Phone
- (617) 936-0960
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1766784
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | New notice | $75,699,630 | $37,849,815 | $37,849,815 | 18 | Dec 10, 2025 | sec.gov |
| Oct 22, 2024 | Amendment | $85,034,866 | $85,034,866 | 17 | Nov 18, 2022 | sec.gov | |
| Nov 9, 2023 | Amendment | $85,034,867 | $60,602,620 | $24,432,247 | 17 | Nov 18, 2022 | sec.gov |
| Dec 2, 2022 | New notice | $31,761,186 | $31,761,186 | 17 | Nov 18, 2022 | sec.gov | |
| Feb 6, 2019 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 7 | Jan 29, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andreas Jurgeit | Director | |
| Bharat Srinivasa | Director | |
| Allan Marchington | Director | |
| Rahul Ballal | Executive Officer, Director | |
| Cassidy Blundell | Director | |
| Maina Bhaman | Director | |
| Adam Cotton | Director | |
| Simon Sturge | Director | |
| Marie-Claire Peakman | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 22, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mediar Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.